Alan Schuster

Apixaban, an oral, direct factor <scp>X</scp>a inhibitor: single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects

Charles Frost, Jessie J. Wang, Sunil Nepal et al. · British Journal of Clinical Pharmacology · 2012 · 363 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor<scp>X</scp>a inhibitor, in healthy subjects

Charles Frost, Sunil Nepal, Jessie Wang et al. · British Journal of Clinical Pharmacology · 2013 · 282 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Liquid chromatography/tandem mass spectrometry methods for quantitation of mevalonic acid in human plasma and urine: method validation, demonstration of using a surrogate analyte, and demonstration of unacceptable matrix effect in spite of use of a stable isotope analog internal standard

Mohammed Jemal, Alan Schuster, Daisy B. Whigan · Rapid Communications in Mass Spectrometry · 2003 · 198 citations

Pharmacy, Biochemistry, Pharmaceutical Analysis +17

Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor<scp>X</scp>a inhibitor

Charles Frost, Wonkyung Byon, Yan Song et al. · British Journal of Clinical Pharmacology · 2014 · 158 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Comparative Metabolism of 14C-Labeled Apixaban in Mice, Rats, Rabbits, Dogs, and Humans

Donglu Zhang, Kan He, Nirmala Raghavan et al. · Drug Metabolism and Disposition · 2009 · 104 citations

Medicine, Pharmacokinetics, Pharmacology +15